Status:
COMPLETED
MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-79 years
Phase:
PHASE3
Brief Summary
This study is to assess the safety and efficacy of an investigational drug as compared to an approved drug to reduce specific cholesterol levels.
Detailed Description
The duration of treatment is 6 weeks.
Eligibility Criteria
Inclusion
- Elevated cholesterol
Exclusion
- Unstable medical conditions or significant heart problems within 3 months prior to first study visit.
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
1902 Patients enrolled
Trial Details
Trial ID
NCT00092690
Start Date
June 1 2003
End Date
March 1 2004
Last Update
May 10 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.